Evidence map›Paper›PMID 29518116›Full record

ArticlePloS one2018

Palmitate and minimally-modified low-density lipoprotein cooperatively promote inflammatory responses in macrophages.

Soo-Jin Ann, Ka-Kyung Kim, Eun Jeong Cheon, Hye-Min Noh, Inhwa Hwang, Je-Wook Yu, Sungha Park, Seok-Min Kang, Ichiro Manabe, Yury I Miller and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Pathophysiology of Atherosclerosis.International journal of molecular sciences · 2022
    Review
  3. Korean circulation journal · 2021
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Soo-Jin AnnDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Ka-Kyung KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Eun Jeong CheonDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Hye-Min NohDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Inhwa HwangDepartment of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, Korea.
Je-Wook YuDepartment of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, Korea.
Sungha ParkDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Seok-Min KangDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Ichiro ManabeDepartment of Disease Biology and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yury I MillerDepartment of Medicine, University of California, San Diego, La Jolla, United States of America.
Sangwoo KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Sang-Hak LeeDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-4535-3745
Yonsei University · KRChiba University · JPUniversity of California San Diego · US

Funding

AIBP therapyR35HL135737 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2017 to 2023
$6.5M
NHLBI NIH HHS R35 HL135737
6 · The paper itself

Abstract

Increased consumption of Western-type diets and environmental insults lead to wide-spread increases in the plasma levels of saturated fatty acids and lipoprotein oxidation. The aim of this study is to examine whether palmitate and minimally modified low-density lipoprotein (mmLDL) exert an additive effect on macrophage activation. We found that CXCL2 and TNF-α secretion as well as ERK and p38 phosphorylation were additively increased by co-treatment of J774 macrophages with palmitate and mmLDL in the presence of lipopolysaccharide (LPS). Furthermore, the analysis of differentially expressed genes using the KEGG database revealed that several pathways, including cytokine-cytokine receptor interaction, and genes were significantly altered. These results were validated with real-time PCR, showing upregulation of Il-6, Csf3, Il-1β, and Clec4d. The present study demonstrated that palmitate and mmLDL additively potentiate the LPS-induced activation of macrophages. These results suggest the existence of synergistic mechanisms by which saturated fatty acids and oxidized lipoproteins activate immune cells.

Indexed as

AnimalsCD36 AntigensCell LineCytokinesDose-Response Relationship, DrugDrug SynergismEscherichia coliGene ExpressionHumansImmunologic FactorsLipopolysaccharidesLipoproteins, LDLMacrophagesMAP Kinase Signaling SystemMicePalmitatesCD36 AntigensCytokinesImmunologic FactorsLipopolysaccharidesLipoproteins, LDLOlr1 protein, mousePalmitatesScavenger Receptors, Class E

Identifiers

PMID29518116
PMCPMC5843266
OpenAlexW2791096285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.